期刊文献+

蛋白酶体抑制剂通过内质网应激途径诱导卵巢癌细胞凋亡的研究 被引量:1

Study on apoptosis of ovarian cancer cells induced by proteasome inhibitor via endoplasmic reticulum stress
下载PDF
导出
摘要 目的:探讨内质网应激在蛋白酶体抑制剂MG132诱导卵巢癌细胞凋亡中的作用。方法:将人卵巢癌细胞系SKOV3设空白对照组、不同浓度MG132处理组、生长停滞及DNA损伤(chop)基因siRNA组、随机序列核酸siRNA组4组。四唑盐比色法和流式细胞术检测细胞活力和凋亡率;实时定量PCR和Western blot检测各组细胞葡萄糖调节蛋白78(grp78)以及chop基因的mRNA和蛋白表达。结果:MG132处理抑制SKOV3细胞活力,增加SKOV3细胞凋亡率。MG132处理还可诱导SKOV3细胞grp78和chop基因的表达。当chop siRNA靶向沉默chop表达后,MG132作用后SKOV3细胞活力明显增加。结论:MG132诱导卵巢癌细胞内质网应激;chop基因介导内质网应激凋亡途径在MG132的抗卵巢癌活性中发挥重要作用。 Objective: To investigate the role of endoplasmic reticulum (ER) stress in ovarian cancer cell apoptosis induced by MG132. Methods: SKOV3 ovarian cancer cells were divided into control group and different concentrations of MG132-treated groups also divided into random small interfering RNA (siRNA) and siRNA specific against chop (sichop). The cells were treated with MG132, cell viability and apoptotic cells were evaluated using MTT assay and flow cytometry, respectively. The grp78 and chop mRNA and protein levels were analyzed using real-time reverse tran- scription polymerase chain reaction and western blot, respectively. Results.. The treatment with MG132 decreased cell viability and increased apoptotic rate. MG132 dose-dependently increased grp78 and chop mRNA and protein expression levels in SKOV3 cells. Knockdown chop induction by sichop significantly increased the viability of SKOV3 cells upon MG132 exposure. Conclusion: MG132 induces ER stress in ovarian cancer cells. The chop-mediated apoptotic signal of ER stress might play a critical role in MG132-induced cytotoxicity of ovarian cancer cells.
出处 《中国计划生育学杂志》 2015年第8期520-523,529,共5页 Chinese Journal of Family Planning
关键词 内质网应激 蛋白酶体抑制剂 MG132、SKOV3、SiRNA、chop基因 卵巢癌 Endoplasmic reticulum stress Proteasome inhibitor MG132 SKOV3 Small interfering RNA Chop gene Ovarian cancer
  • 相关文献

参考文献15

  • 1Bhattacharyya S,Yu H,Mim C,et al.Regulated protein turnover:snapshots of the proteasome in action[J].Nat Rev Mol Cell Biol,2014,15(2):122-133.
  • 2Kleiger G,Myor T.Perilous journey:a tour of the ubiquitinproteasome system[J].Trends Cell Biol,2014,24(6):352-359.
  • 3Schmidt M,Finley D.Regulation of proteasome activity in health and disease[J].Biochim Biophys Acta,2014,1843(1):13-25.
  • 4Amm I,Sommer T,Wolf DH.Protein quality control and elimination of protein waste:the role of the ubiquitin-proteasome system[J].Biochim Biophys Acta,2014,1843(1):182-196.
  • 5Zhang T,Ye Y.The final moments of misfolded proteins en route to the proteasome[J].DNA Cell Biol,2014,33(8):477-483.
  • 6Ding F,Xiao H,Wang M,et al.The role of the ubiquitin-proteasome pathway in cancer development and treatment[J].Front Biosci,2014,19:886-895.
  • 7Huang Z,Wu Y,Zhou X,et al.Efficacy of therapy with bortezomib in solid tumors:a review based on 32clinical trials[J].Future Oncol,2014,10(10):1795-1807.
  • 8Johnson D.The ubiquitin-proteasome system:opportunities for therapeutic intervention in solid tumors[J].Endocr Relat Cancer,2015,22(1):T1-17.
  • 9Shen M,Schmitt S,Buac D,et al.Targeting the ubiquitinproteasome system for cancer therapy[J].Expert Opin Ther Targets,2013,17(9):1091-1108.
  • 10Bassermann F,Eichner R,Pagano M.The ubiquitin proteasome system-implications for cell cycle control and the targeted treatment of cancer[J].Biochim Biophys Acta,2014,1843(1):150-162.

同被引文献13

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部